Fountain Therapeutics Congratulates Co-Founder and Executive Chairman Thomas Rando, M.D., Ph.D., for Prestigious NOMIS Distinguished Scientist Award
October 05, 2022 08:00 ET
|
Fountain Therapeutics
SAN FRANCISCO, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Fountain Therapeutics (“Fountain”), a biopharmaceutical company leveraging proprietary breakthroughs in artificial intelligence and computational...
Fountain Therapeutics Announces Appointment of Anupama Hoey as Chief Business Officer
January 18, 2022 08:00 ET
|
Fountain Therapeutics
SAN FRANCISCO, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Fountain Therapeutics (“Fountain”), a biopharmaceutical company leveraging a unique artificial intelligence platform driven by expertise in aging...
Fountain Therapeutics Announces $15 Million Series A-2 Financing
November 18, 2021 08:00 ET
|
Fountain Therapeutics
Brings total Series A financing to $26 million Funds to support expansion of leadership team, continued R&D activities and pre-clinical research SAN FRANCISCO, Nov. 18, 2021 (GLOBE NEWSWIRE)...
Fountain Therapeutics to Present at 2nd Annual LifeSci Partners Private Company Summer Symposium
July 19, 2021 08:30 ET
|
Fountain Therapeutics
SOUTH SAN FRANCISCO, Calif., July 19, 2021 (GLOBE NEWSWIRE) -- Fountain Therapeutics, a biopharmaceutical company building a pipeline of therapeutics to treat age-related diseases by reversing...
Fountain Therapeutics Appoints William L. Greene, M.D. Chief Executive Officer
April 26, 2021 08:00 ET
|
Fountain Therapeutics
SOUTH SAN FRANCISCO, Calif., April 26, 2021 (GLOBE NEWSWIRE) -- Fountain Therapeutics, a biopharmaceutical company building a pipeline of therapeutics to treat age-related diseases by reversing...
Fountain Therapeutics Moves Corporate Headquarters to Lilly Gateway Labs in South San Francisco
September 09, 2020 09:30 ET
|
Fountain Therapeutics
SAN FRANCISCO, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Fountain Therapeutics (“Fountain”), a biopharmaceutical company building a pipeline of therapeutics to treat age-related diseases by reversing...
Fountain Therapeutics Closes $6 Million Series A-1 Financing
May 19, 2020 09:15 ET
|
Fountain Therapeutics
Closing brings total Series A financing sum to $11 million Funds to support expansion of team, technology platform and in vivo preclinical drug testing SAN FRANCISCO, May 19, 2020 (GLOBE...